## 1,4-Dihydropyrimidine: An Important Scaffold in Medicinal Chemistry
1,4-Dihydropyrimidine is a heterocyclic compound containing a six-membered ring with two nitrogen atoms and a double bond between carbons 1 and 4. It serves as a **fundamental scaffold** in medicinal chemistry due to its **versatile nature and potential for biological activity**.
**Here's why it's important in research:**
* **Diverse Biological Activity:** 1,4-Dihydropyrimidines have shown a broad range of biological activities, including:
* **Anti-cancer properties:** Some derivatives have shown potent anticancer activity against various cancer cell lines.
* **Anti-inflammatory effects:** They can inhibit inflammation by targeting specific enzymes and pathways.
* **Antimicrobial activity:** Some 1,4-dihydropyrimidines exhibit promising antibacterial and antifungal properties.
* **Cardiovascular activity:** They can regulate blood pressure and heart rate.
* **Neurological activity:** Certain derivatives can modulate neuronal activity and have potential for treating neurological disorders.
* **Synthetic Accessibility:** The core structure of 1,4-dihydropyrimidine is relatively easy to synthesize, allowing for the rapid creation of diverse derivatives with varying pharmacological properties.
* **Structural Modification:** The scaffold can be easily modified through various chemical reactions, enabling researchers to fine-tune its properties and optimize its efficacy. This allows for the creation of **highly specific drugs** that target specific biological pathways.
* **Drug Discovery Potential:** The versatile nature of 1,4-dihydropyrimidines makes it a valuable starting point for **drug discovery and development**. Researchers can design and synthesize numerous derivatives with different pharmacological profiles, leading to potential new therapeutic agents.
**Examples of 1,4-Dihydropyrimidine-based drugs:**
* **Fingolimod:** An immunosuppressant used to treat multiple sclerosis.
* **Nilotinib:** A tyrosine kinase inhibitor used to treat chronic myeloid leukemia.
* **Sorafenib:** A multi-kinase inhibitor used to treat liver cancer.
**Current research focus:**
* **New synthetic methods:** Development of efficient and sustainable synthetic strategies to access diverse 1,4-dihydropyrimidine derivatives.
* **Structure-activity relationship (SAR):** Investigating the relationship between the structure of 1,4-dihydropyrimidines and their biological activity.
* **Target identification:** Determining the specific molecular targets of 1,4-dihydropyrimidines to understand their mechanism of action.
* **Drug development:** Optimizing the pharmacokinetic and pharmacodynamic properties of 1,4-dihydropyrimidines to improve their therapeutic efficacy.
In conclusion, 1,4-dihydropyrimidine is a valuable scaffold in medicinal chemistry, offering a vast potential for developing new and effective drugs for a variety of diseases. Ongoing research efforts aim to further explore its therapeutic potential and translate it into new treatments for patients.
1,4-dihydropyrimidine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 5248048 |
CHEMBL ID | 122235 |
MeSH ID | M0591369 |
Synonym |
---|
1,4-dihydropyrimidine |
CHEMBL122235 |
1,6-dihydro-pyrimidine |
AKOS006372234 |
3,4-dihydropyrimidine |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID216184 | Tested for inhibitory effect on RNA virus cell morphology in Vero cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID82887 | Tested for inhibitory effect on DNA virus CMV (AD-169) in HEL cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID68128 | Tested for inhibitory effect on DNA virus TK-HSV-1(VMW 1837) in ESM cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID105777 | Tested for inhibitory effect on RNA virus cell morphology in MDCK cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID68126 | Tested for inhibitory effect on DNA virus HSV-2 (G) in ESM cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID216177 | Tested for inhibitory effect on RNA virus Coxsackie B4 in Vero cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID68127 | Tested for inhibitory effect on DNA virus TK-HSV-1 (B2006) in ESM cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID216180 | Tested for inhibitory effect on RNA virus Reo-1 in Vero cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID216179 | Tested for inhibitory effect on RNA virus PV-3 in Vero cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID88685 | Tested for inhibitory effect on RNA virus Polio-1 in HeLa cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID216181 | Tested for inhibitory effect on RNA virus SFV in Vero cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID82888 | Tested for inhibitory effect on DNA virus CMV (Davis) in HEL cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID216182 | Tested for inhibitory effect on RNA virus SV in Vero cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID68130 | Tested for inhibitory effect on RNA virus cell morphology in ESM cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID68125 | Tested for inhibitory effect on DNA virus HSV-1(KOS) in ESM cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID88688 | Tested for inhibitory effect on RNA virus cell morphology in HeLa cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID68129 | Tested for inhibitory effect on DNA virus VV in ESM cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID88687 | Tested for inhibitory effect on RNA virus VSV in HeLa cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
AID82893 | Tested for inhibitory effect on RNA virus cell growth in HEL cell line | 1993 | Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23 | Synthesis and antiviral activity of 5'-deoxypyrazofurin. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (77.78) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.08) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |